Microcirculation in arterial hypertension patients receiving beta-adrenoblockers
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
Aim. To compare microcirculation (MC) functional status during the treatment with beta-adrenoblockers (BAB), with and without vasodilatatory effects, in patients with Stage I-II arterial hypertension (AH). Material and methods. In total, 61 Stage I-II patients and 30 relatively healthy volunteers were examined. AH patients received nebivolol or metoprolol for 24 weeks. At baseline, and after 4, 12, and 24 weeks, MC hemodynamic types (MCHT) were assessed by laser Doppler flowmetry (LAKK-02 device, “LASMA”, Russia). Ключевые слова: артериальная гипертония, состояние микроциркуляции, гемодинамические типы микроциркуляции, β-адреноблокаторы, небиволол, метопролол. Results. AH is characterized by heterogeneous MC changes: hyperemic MCHT is typical for Stage I AH, and stasis-congestive or spastic MCHT – for Stage II AH. During metoprolol therapy, normocirculatory MCHT increased, and hyperemic MCHT decreased. Nebivolol demonstrated normalizing effects, manifesting in decreased hyperemic or spastic MCHT and increased normocirculatory MCHT. Conclusion. Metoprolol improved MC functional status. Nebivolol normalized functional and morphological MC status.
About the Authors
L. L. KirichenkoRussian Federation
O. V. Vostryakova
Russian Federation
Yu. A. Babich
Russian Federation
N. V. Burlyay
Russian Federation
Zh. I. Vasheva
Russian Federation
A. P. Korolev
Russian Federation
O. B. Golovkova
Russian Federation
References
1. Mareev V.Yu., Belenkov Yu.N. Dolzhny li izmenyat'sya vzglyady rossiiskikh vrachei na printsipy lecheniya arterial'noi gipertonii v svete rezul'tatov issledovaniya ALLHAT. Serdtse 2003; 2(1): 38-44.
2. Makolkin V.I., Podzolkov V.I., Bran'ko V.V., Samoilenko V.V. Mikrotsirkulyatsiya v kardiologii. Moskva: Vizart 2004; 136 s.
3. Prichard B, Cruickshank J, Graham B. Beta-adrenergic blocking drugs in the treatment of hypertension. Blood Pressure 2001; 10: 366-86.
4. Schiffrin EL, Deng LY, Larochelle P. Effect of a beta-blocer o ACEi on resistance arteries. Hypertension 1994; 23: 83-91.
5. Winther K, Klysner R, Geisler A, Andersen PH. Characterisation of human platelet beta- adrenoceptors. Thromb Res 1995; 40: 757-67.
6. Turacli O, Struijer-Boudier H, Noble J, et al. The microcirculation and hypertension. J Hypertens 1992; 10: S147-56.
7. Makolkin V.I., Podzolkov V.I., Pavlov V.I., Samoilenko V.V. Sostoyanie mikrotsirkulyatsii pri gipertonicheskoi bolezni. Kardiologiya 2003; 5: 60-7.
Review
For citations:
Kirichenko L.L., Vostryakova O.V., Babich Yu.A., Burlyay N.V., Vasheva Zh.I., Korolev A.P., Golovkova O.B. Microcirculation in arterial hypertension patients receiving beta-adrenoblockers. Cardiovascular Therapy and Prevention. 2006;5(6):27-31. (In Russ.)
ISSN 2619-0125 (Online)